Shisi Pharmaceutical Group (02005): Azithromycin dispersible tablets (0.25g) passed the consistent evaluation of generic drug quality and efficacy

Zhitong Finance App News, Shijiyao Group (02005) announced that the group's azithromycin dispersible tablets (0.25g) have obtained approval from China's State Drug Administration to pass the consistent evaluation of generic drug quality and efficacy. Azithromycin is a macrolide antimicrobial drug mainly used to treat mild to moderate infections caused by designated sensitive strains of microorganisms.